Fig 1.
A flow diagram of study participants.
*There is no overlap between training and validation cohorts.
Table 1.
Characteristics of critically ill patients in training and validation cohorts.
Table 2.
Univariate and multivariate analysis of the associations between 30-day mortality and Glucose Variables with SAPS II in training cohort.
Fig 2.
ROC analysis of the prognostic efficiency of GV-SAPS II score and other models to predict short-term and long-term outcomes in training cohort and validation cohort.
Table 3.
Performance parameters of scoring system as predictors of short-term and long-term mortality of critically ill subjects.
Fig 3.
Survival distributions of different risk levels of the GV-SAPS II scoring system in the training and validation cohort.